Atara Biotherapeutics, Inc. (ATRA)
NASDAQ · Healthcare
Atara Biotherapeutics, Inc. Revenue 2022–2025
Atara Biotherapeutics, Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Atara Biotherapeutics, Inc. revenue for the quarter ending March 31, 2026 was 516000, a 99.47% decrease year-over-year.
- Atara Biotherapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 119.7 M, a 21.73% increase year-over-year.
- Atara Biotherapeutics, Inc. annual revenue for 2025 was 120.8 M, a 6.33% decrease from 2024.
- Atara Biotherapeutics, Inc. annual revenue for 2024 was 128.9 M, a 1404.02% increase from 2023.
- Atara Biotherapeutics, Inc. annual revenue for 2023 was 8.6 M, a 86.51% decrease from 2022.
- Atara Biotherapeutics, Inc. annual revenue for 2022 was 63.6 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Atara Biotherapeutics, Inc. Market Cap — FAQ
Atara Biotherapeutics, Inc. (ATRA) market cap over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATRA's market cap history?
The chart and table above show Atara Biotherapeutics, Inc.'s market cap by year and by quarter, including the growth rate.